09/25/2020 | 09:50am EDT

BRAIN Group

Pioneering Bioproducts

Investor Presentation

Zwingenberg, September 15th, 2020

Pioneering Bioproducts.

BRAIN Aktiengesellschaft Zwingenberg Germany http://www.brain-biotech.com +49 (0) 6251-9331-0

1

Safe Harbor Statement

This document may contain forward-looking statements. These forward-looking statements are subject to risks and uncertainties, as they relate to future events and are based on current assumptions of the Company, which may not occur at all in the future or may not occur as assumed. They do not represent a guarantee for future results or performance of the Company, and the development of economic and legal conditions may materially differ from the information expressed or implied in the forward-looking statements.

The Company assumes no obligation to update or revise any forward-looking statement contained herein or to adapt them to future events or developments. The information contained in this document has not been independently verified. No representation or warranty expressed or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinion contained herein. The Company or any of its shareholders, affiliates, advisors, employees or representatives shall have no liability whatsoever (in negligence or otherwise) for any loss arising from any use of this document or its content or otherwise arising in connection with this document.

By accepting this presentation you acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsibility for forming your own view of the potential future performance of the Company's business.

This presentation speaks as of September 15th, 2020. Neither the delivery of this presentation nor any further discussions of the Company with any of the recipients shall, under any circumstances, create any implication that there has been no change in the affairs of the Company since such date. The term "BRAIN", as used in this presentation means B.R.A.I.N. Biotechnology Research and Information Network AG and its affiliates, if not otherwise specified.

Pioneering Bioproducts.

BRAIN Aktiengesellschaft Zwingenberg Germany http://www.brain-biotech.com +49 (0) 6251-9331-0

2

Brain at a Glance

~ 39m

'18/'19 Revenues

> 27

Years of Experience

~ 300

Employees

> 100

Specialty B2B Products

> 100

Industrial Partnerships

2016

Listed, Frankfurt Prime Standard

Creating Breakthrough Bioproducts & Solutions for Nutrition, Health and Environment

Industrial Biotech

Three

(white)

Product Platforms

Enzymes

Microorganisms

Bioactive

Natural

Compounds

From the Lab to Production

Pioneering Bioproducts.

BRAIN Aktiengesellschaft Zwingenberg Germany http://www.brain-biotech.com +49 (0) 6251-9331-0

3

Mission & Vision

"Mission is what an organization is or does. Vision is what an organization desires to become"

Mission

Creating Breakthrough Bioproducts and Solutions for Nutrition, Health and the Environment

Vision

We will be the Industrial/White Biotech Specialists in finding and exploring high-value niches in our products business and novel solutions in our Science business. We will be much more agile than others and will always look to produce products in-house or with partners

Pioneering Bioproducts.

BRAIN Aktiengesellschaft Zwingenberg Germany http://www.brain-biotech.com +49 (0) 6251-9331-0

4

This is Brain

Brain AG

BioScienceBioIndustrial

Solutions & Services

Products

Breakthroughs

Stable Service Business with Upside

Innovation & Optimization

Own and Partnered NBD TMS BioActive Compound Libraries Enzymes Microorganisms Bioactives

~ 5m-7m Annual

~ 12m Annual Revenues*

~ 26m Annual Revenues

Cost-plus Contract research,

Investment

>10% EBITDA Margin*

Milestones, Technology & License Fees

*FY '18/'19

Pioneering Bioproducts.

BRAIN Aktiengesellschaft Zwingenberg Germany http://www.brain-biotech.com +49 (0) 6251-9331-0

5

Why Invest in BRAIN

Multiple Triggers for strong Revenue and Margin Growth

Pioneering Bioproducts.

BRAIN Aktiengesellschaft Zwingenberg Germany http://www.brain-biotech.com +49 (0) 6251-9331-0

6

BRAIN: At the Heart of UN Sustainable Development Goals

Our Products and Solutions address at least six Goals directly

Sugar Replacement

Sugar Taste Enhancer

Salt Replacement

Salt Taste Enhancer

Natural Aromas

Anti-Microbials Wound Treatment

Natural Preservatives Bioactive Plant Cosmetics

Green Mining

Phosphate Recycling

Green Mining Microbial CO2 Usage

Biological Production

Urban Mining

Improving Production Efficiencies

Fermented Food from Sidestreams

Pioneering Bioproducts.

BRAIN Aktiengesellschaft Zwingenberg Germany

http://www.brain-biotech.com +49 (0) 6251-9331-0

7

Our Targets

This FY

Read the original:
BRAIN Biotechnology Research and Information Network : BRAIN - Investor Presentation - Marketscreener.com